Radiation detriment calculation methodology: summary of ICRP Publication 152.

ICRP nominal risk radiation detriment sensitivity analysis stochastic effects

Journal

Journal of radiological protection : official journal of the Society for Radiological Protection
ISSN: 1361-6498
Titre abrégé: J Radiol Prot
Pays: England
ID NLM: 8809257

Informations de publication

Date de publication:
29 04 2022
Historique:
received: 22 02 2022
accepted: 13 04 2022
pubmed: 14 4 2022
medline: 3 5 2022
entrez: 13 4 2022
Statut: epublish

Résumé

Radiation detriment is a concept to quantify the burden of stochastic effects from exposure of the human population to low-dose and/or low-dose-rate ionising radiation. As part of a thorough review of the system of radiological protection, the International Commission on Radiological Protection (ICRP) has compiled a report on radiation detriment calculation methodology as Publication 152. It provides a historical review of the detriment calculation with details of the procedure used in ICRP Publication 103. A selected sensitivity analysis was conducted to identify the parameters and calculation conditions that can be major sources of variation and uncertainty. It has demonstrated that sex, age at exposure, dose and dose-rate effectiveness factor, dose assumption in the lifetime risk calculation, and lethality fraction have a substantial impact on the calculated values of radiation detriment. Discussions are also made on the issues to be addressed and possible ways for improvement toward the revision of general recommendations. These include update of the reference population data and cancer severity parameters, revision of cancer risk models, and better handling of the variation with sex and age. Finally, emphasis is placed on transparency and traceability of the calculation, along with the need to improve the way of expressing and communicating the detriment.

Identifiants

pubmed: 35417894
doi: 10.1088/1361-6498/ac670d
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022 Society for Radiological Protection. Published on behalf of SRP by IOP Publishing Limited. All rights reserved.

Auteurs

Nobuhiko Ban (N)

Nuclear Regulation Authority, Tokyo, Japan.

Enora Cléro (E)

Health and Environmental Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.

Ludovic Vaillant (L)

Centre d'etude sur l'Evaluation de la Protection dans le domaine Nucleaire (CEPN), Fontenay-aux-Roses, France.

Wei Zhang (W)

Radiation, Chemical and Environmental Hazards Directorate, UK Health Security Agency, Oxon, United Kingdom.

Nobuyuki Hamada (N)

Radiation Safety Unit, Biology and Environmental Chemistry Division, Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), Tokyo, Japan.

Dale Preston (D)

Hirosoft International Corporation, Eureka, CA, United States of America.

Dominique Laurier (D)

Health and Environmental Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH